Clinical trials: Comparative Bioavailability

Women at Risk for Pregnancy

A PK Study Comparing VeraCept vs. ParaGard Intrauterine Devices (IUDs)

• Completed
• Age: Up to 45 years
• Phase 3
• Results posted

to Assess the Pharmacokinetic Properties of VeraCept® Intrauterine Contraceptive vs ParaGard® in Healthy, Post- Menarcheal Women

Trial name

IUD (NCT03785366)

Testing

VeraCept, ParaGard

Where

2 sites in United States

Volunteers

41 people, healthy volunteers welcome

Sponsor

Sebela Women's Health Inc.